Impaired glucose tolerance

BMJ

Volumn 312, Issue 7026, 1996, Pages 264-265

  Davies, Melanie J ^a   Gray, I Peter ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

EDITORIAL; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; DIABETES MELLITUS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIA; MIDDLE AGED;

EID: 0030033158     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.312.7026.264     Document Type: Editorial

References (20)

1. World Health Organisation Expert Committee on Diabetes Mellitus. Second Report. Tech Rep Ser 1980;No 646.
2. Jarrett RJ, Keen H. Hyperglycaemia and diabetes mellitus. Lancet 1976; 2: 1009–12.
3. Yudkin JS, Alberti KGMM, Mclarty DG, Swai ABM. Impaired glucose tolerance: is it a risk factor for diabetes or a diagnostic ragbag? BMJ 1990; 301: 397–401.
4. Harris M. Impaired glucose tolerance in the US population. Diabetes Care 1989; 12: 464–474.
5. Brown DC, Byrne CD, Clark PMS, Cox L, Day NE, Hales CN, et al Height and glucose tolerance in adult subjects. Diabetologia 1991; 34: 531–533.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
7. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranto C, Widen E, Schalin C, et al Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337–343.
8. Davies MJ, Rayman G, Grenfell A, Gray IP, Day JL, Hales CN. Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabetic Med 1994; 11: 432–436.
9. O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 1988; 318: 1225–30.
10. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1980: 1: 1373–6.
11. Jarrett RJ, Shipley MJ. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease: putative association via common antecedents; further evidence from the Whitehall study. Diabetologia 1988; 31: 737–741.
12. West KM, Ahuja MMS, Bennett PH, Czczyk A, Mateo de Acosta O, Fuller JH, et al The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic populations samples from the WHO multinational study. Diabetes Care 1983; 6: 361–369.
13. Davies MJ, Rayman G, Day JL. Increased cardiovascular mortality in subjects with impaired glucose tolerance link with serum lipoprotein(a). BMJ 1992; 304: 1610–1.
14. Keen H, Jarrett RJ, McCartney P. The ten-year follow up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 1982; 22: 73–78.
15. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, et al Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44–49.
16. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabetic Med 1993; 10: 313–320.
17. Saad MF, Knowler WC, Pettitt DJ, Nelson RJ, Bennett PH. Transient impaired glucose tolerance in Pima Indians: is it important? BMJ 1988; 297: 1438–40.
18. United Kingdom Prospective Diabetes Study Group. UK prospective diabetes study (UKPDS) XII. Differences between Asian, Afro-Caribbean and White Caucasian Type 2 diabetic patients at diagnosis of diabetes. Diabetic Med 1994; 11: 670–677.
19. Jarrett RJ, Keen H, Fuller JH, McCartney M. Worsening to diabetes in men with impaired glucose tolerance. Diabetologia 1979; 16: 25–30.
20. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study. Diabetologia 1991; 24: 891–898.